Murine intracochlear drug delivery: reducing concentration gradients within the cochlea.
Direct delivery of compounds to the mammalian inner ear is most commonly achieved by absorption or direct injection through the round window membrane (RWM), or infusion through a basal turn cochleostomy. These methods provide direct access to cochlear structures, but with a strong basal-to-apical concentration gradient consistent with a diffusion-driven distribution. This gradient limits the efficacy of therapeutic approaches for apical structures, and puts constraints on practical therapeutic dose ranges. A surgical approach involving both a basal turn cochleostomy and a posterior semicircular canal canalostomy provides opportunities for facilitated perfusion of cochlear structures to reduce concentration gradients. Infusion of fixed volumes of artificial perilymph (AP) and sodium salicylate were used to evaluate two surgical approaches in the mouse: cochleostomy-only (CO), or cochleostomy-plus-canalostomy (C+C). Cochlear function was evaluated via closed-system distortion product otoacoustic emissions (DPOAE) threshold level measurements from 8 to 49 kHz. AP infusion confirmed no surgical impact to auditory function, while shifts in DPOAE thresholds were measured during infusion of salicylate and AP (washout). Frequency dependent shifts were compared for the CO and C+C approaches. Computer simulations modeling diffusion, volume flow, interscala transport, and clearance mechanisms provided estimates of drug concentration as a function of cochlear position. Simulated concentration profiles were compared to frequency-dependent shifts in measured auditory responses using a cochlear tonotopic map. The impact of flow rate on frequency dependent DPOAE threshold shifts was also evaluated for both surgical approaches. Both the C+C approach and a flow rate increase were found to provide enhanced response for lower frequencies, with evidence suggesting the C+C approach reduces concentration gradients within the cochlea.
Borkholder
David A
DA
Department of Electrical and Microelectronic Engineering, Rochester Institute of Technology, Rochester, NY 14623, USA. david.borkholder@rit.edu
Zhu
Xiaoxia
X
Hyatt
Brad T
BT
Archilla
Alfredo S
AS
Livingston
William J
WJ
Frisina
Robert D
RD
D000818:Animals; D003051:Cochlea / Q000187:drug effects* / Q000378:metabolism / Q000601:surgery; D003198:Computer Simulation; D004058:Diffusion; D016503:Drug Delivery Systems; D007263:Infusions, Parenteral; D051379:Mice; D008808:Mice, Inbred CBA; D008954:Models, Biological; D017084:Otoacoustic Emissions, Spontaneous / Q000187:drug effects; D013506:Otologic Surgical Procedures; D010498:Perilymph / Q000378:metabolism; D012980:Sodium Salicylate / Q000008:administration & dosage*
D012980:Sodium Salicylate
Hear Res. 2001 May;155(1-2):1-8
11335071
Annu Int Conf IEEE Eng Med Biol Soc. 2007;2007:6617-20
18003542
Otol Neurotol. 2002 Nov;23(6):967-74
12438864
Science. 2001 Jun 22;292(5525):2340-3
11423665
Otol Neurotol. 2008 Apr;29(3):401-6
18277312
Mol Ther. 2001 Dec;4(6):575-85
11735342
Gene Ther. 2000 Mar;7(5):377-83
10694819
Laryngoscope. 1999 Oct;109(10):1661-8
10522939
Audiol Neurootol. 2007;12(1):37-48
17119332
J Neurosci Methods. 1992 Oct-Nov;45(1-2):127-34
1491594
Hear Res. 2003 Sep;183(1-2):37-43
13679136
Hear Res. 2003 Feb;176(1-2):122-7
12583887
J Neurosci Methods. 2006 Jan 15;150(1):67-73
16043228
Hear Res. 1991 Nov;56(1-2):37-43
1769923
Audiol Neurootol. 2005 May-Jun;10(3):145-52
15724085
Prog Neurobiol. 2000 Dec;62(6):583-631
10880852
Hear Res. 2007 Aug;230(1-2):43-52
17616288
J Control Release. 2005 Dec 10;110(1):1-19
16274830
Hear Res. 2001 Jan;151(1-2):106-114
11124456
Ear Hear. 1990 Apr;11(2):82-92
2187727
Curr Opin Otolaryngol Head Neck Surg. 2008 Oct;16(5):472-7
18797291
Hear Res. 2005 Apr;202(1-2):63-73
15811700